Propanc Biopharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Propanc Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2024.
  • Propanc Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2024 was $216K, a 38.4% decline year-over-year.
  • Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $942K, a 15.4% decline from 2023.
  • Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.11M, a 25.3% decline from 2022.
  • Propanc Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.49M, a 40.9% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $942K -$172K -15.4% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-30
2023 $1.11M -$377K -25.3% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-30
2022 $1.49M +$433K +40.9% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-28
2021 $1.06M -$832K -44% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-28
2020 $1.89M -$228K -10.8% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
2019 $2.12M -$278K -11.6% Jul 1, 2018 Jun 30, 2019 10-K 2020-10-01
2018 $2.4M +$298K +14.2% Jul 1, 2017 Jun 30, 2018 10-K 2019-10-15
2017 $2.1M Jul 1, 2016 Jun 30, 2017 10-K 2018-09-17
2013 $128K -$41.9K -24.6% Jul 1, 2012 Jun 30, 2013 10-K 2013-10-15
2012 $170K -$1.25M -88% Jul 1, 2011 Jun 30, 2012 10-K 2013-10-15
2011 $1.42M Jul 1, 2010 Jun 30, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.